Borzomed 3.5mg (Bortezomib)

Borzomed 3.5mg Injection is used in the treatment of multiple myeloma and mantle-cell lymphoma. It shows its working by stopping or slowing down the growth of cancer cells.

Brand NameBorzomed
CompostionBortezomib Injection
Country of originMade in India
FormInjection
ManufacturerMedicamen Biotech Ltd
Packaging TypeVial
Strength3.5 mg
Treatmentmultiple myeloma

Description

Borzomed 3.5mg Injection is used in the treatment of multiple myeloma and mantle-cell lymphoma. It shows its working by stopping or slowing down the growth of cancer cells.

Borzomed 3.5mg Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

Fatigue, nausea, vomiting, and loss of appetite are some common side effects of this medicine. You may be advised to drink plenty of fluids every day during the treatment. You should not drive or operate machinery as medicine may cause tiredness and dizziness. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels.

Before taking Borzomed 3.5mg Injection, consult with your doctor if you have any liver, kidney, heart disease or bleeding problem.  It is important to consult a doctor if you develop symptoms like memory loss or trouble in thinking. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.

We have strong global networks in AFRICA, Europe, United Kingdom, United States, Chile, Peru, Ethiopia, Romania, China, Japan, Russia, Ukraine, Dubai, Unites Arab Emirates, Thailand, Vietnam, Middle East and South East Countries.

Explore more more products pharmaceutical injection

Pharmaceutical Injection – Globmedindia

Additional information

Brand Name

Borzomed

Compostion

Bortezomib Injection

Country of origin

Made in India

Form

Injection

Manufacturer

Medicamen Biotech Ltd

Packaging Type

Vial

Strength

3.5 mg

Treatment

multiple myeloma

Reviews

There are no reviews yet.

Be the first to review “Borzomed 3.5mg (Bortezomib)”

Your email address will not be published. Required fields are marked *